Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Change in Receivables (2024 - 2025)

Historic Change in Receivables for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $168000.0.

  • Beta Bionics' Change in Receivables rose 11122.99% to $168000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year change of. This contributed to the annual value of $7.6 million for FY2024, which is 6951.49% up from last year.
  • As of Q3 2025, Beta Bionics' Change in Receivables stood at $168000.0, which was up 11122.99% from $2.3 million recorded in Q2 2025.
  • Beta Bionics' Change in Receivables' 5-year high stood at $4.6 million during Q4 2024, with a 5-year trough of -$2.9 million in Q1 2025.